Life ScienceCompany
Cambridge Cancer Genomics Ownership
Who owns Cambridge Cancer Genomics?
Cambridge Cancer Genomics is owned by Dante Labs. It was acquired on June 23, 2021.
Cambridge Cancer Genomics Business Overview
Where is Cambridge Cancer Genomics headquartered?
Cambridge Cancer Genomics is headquartered in Cambridge, United Kingdom.
What sector is Cambridge Cancer Genomics in?
Cambridge Cancer Genomics is a life science company.
Life Science M&A Summary in 2021
Out of 60 sectors in the Mergr database, life science ranked 7 in number of deals in 2021. The largest life science acquisition in 2021 was Pharmaceutical Product Development - which was acquired by Thermo Fisher Scientific for $17.4B.
Join Mergr to view all 397 acquisitions of life science companies in 2021, including 46 acquisitions by private equity firms, and 351 by strategics.